Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG:

tamoxifen

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Company:

Generic mfg.

Drug class:

Estrogen receptor antagonist

Related drugs:

‹

Z-endoxifen hydrochloride (2)

Z-endoxifen hydrochloride (2)

›

No biomarker	Peritoneal Cancer	No biomarker	Peritoneal Cancer	tamoxifen Sensitive: A2 - Guideline tamoxifen Sensitive : A2	tamoxifen Sensitive: A2 - Guideline tamoxifen Sensitive : A2
No biomarker	Fallopian Tube Cancer	No biomarker	Fallopian Tube Cancer	tamoxifen Sensitive: A2 - Guideline tamoxifen Sensitive : A2	tamoxifen Sensitive: A2 - Guideline tamoxifen Sensitive : A2
No biomarker	Ovarian Cancer	No biomarker	Ovarian Cancer	tamoxifen Sensitive: A2 - Guideline tamoxifen Sensitive : A2	tamoxifen Sensitive: A2 - Guideline tamoxifen Sensitive : A2
HR positive + HER-2 negative	Male Breast Cancer	HR positive + HER-2 negative	Male Breast Cancer	tamoxifen Sensitive: A2 - Guideline tamoxifen Sensitive : A2	tamoxifen Sensitive: A2 - Guideline tamoxifen Sensitive : A2
HER-2 negative	HER2 Negative Breast Cancer	HER-2 negative	HER2 Negative Breast Cancer	tamoxifen Sensitive: A2 - Guideline tamoxifen Sensitive : A2	tamoxifen Sensitive: A2 - Guideline tamoxifen Sensitive : A2
HR positive	Male Breast Cancer	HR positive	Male Breast Cancer	tamoxifen Sensitive: A2 - Guideline tamoxifen Sensitive : A2	tamoxifen Sensitive: A2 - Guideline tamoxifen Sensitive : A2
ER positive	Male Breast Cancer	ER positive	Male Breast Cancer	tamoxifen Sensitive: A2 - Guideline tamoxifen Sensitive : A2	tamoxifen Sensitive: A2 - Guideline tamoxifen Sensitive : A2
No biomarker	Endometrial Cancer	No biomarker	Endometrial Cancer	tamoxifen + medroxyprogesterone Sensitive: A2 - Guideline tamoxifen + medroxyprogesterone Sensitive : A2	tamoxifen + medroxyprogesterone Sensitive: A2 - Guideline tamoxifen + medroxyprogesterone Sensitive : A2
No biomarker	Endometrial Cancer	No biomarker	Endometrial Cancer	tamoxifen Sensitive: A2 - Guideline tamoxifen Sensitive : A2	tamoxifen Sensitive: A2 - Guideline tamoxifen Sensitive : A2
No biomarker	Endometrial Cancer	No biomarker	Endometrial Cancer	tamoxifen + megestrol Sensitive: A2 - Guideline tamoxifen + megestrol Sensitive : A2	tamoxifen + megestrol Sensitive: A2 - Guideline tamoxifen + megestrol Sensitive : A2
ESR1 wild-type + HR positive	HER2 Positive Breast Cancer	ESR1 wild-type + HR positive	HER2 Positive Breast Cancer	tamoxifen Sensitive: A2 - Guideline tamoxifen Sensitive : A2	tamoxifen Sensitive: A2 - Guideline tamoxifen Sensitive : A2
ESR1 mutation + HR positive	HER2 Negative Breast Cancer	ESR1 mutation + HR positive	HER2 Negative Breast Cancer	tamoxifen Sensitive: A2 - Guideline tamoxifen Sensitive : A2	tamoxifen Sensitive: A2 - Guideline tamoxifen Sensitive : A2